darifenacin

chemical compound

Wikidata entity: Q166476

C₂₈H₃₀N₂O₂ (P274)


Wikimedia Commons category is Darifenacin

Quantities

P4250defined daily dose7.5
P2067mass426.231

P3780 active ingredient in ... Q47521438 (Enablex) Enablex
P233 canonical SMILES String C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5 ???
P373 Commons category String Darifenacin ???
P366 has use ... Q12140 (medication) medication
P31 instance of ... Q113145171 (type of chemical entity) type of chemical entity
P2017 isomeric SMILES String C1CN(C[C@@H]1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5 ???
P129 physically interacts with ... Q2844056 (Cholinergic receptor muscarinic 3) Cholinergic receptor muscarinic 3
P129 physically interacts with ... Q4847900 (Cholinergic receptor muscarinic 1) Cholinergic receptor muscarinic 1
P129 physically interacts with ... Q4847910 (Cholinergic receptor muscarinic 2) Cholinergic receptor muscarinic 2
P3489 pregnancy category ... Q3679234 (Australian pregnancy category B3) Australian pregnancy category B3
P3489 pregnancy category ... Q28123617 (US pregnancy category C) US pregnancy category C
P769 significant drug interaction ... Q421381 (flecainide) flecainide
P279 subclass of ... Q126615921 (2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide) 2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide
P2868 subject has role ... Q3001265 (muscarinic antagonist) muscarinic antagonist
P2868 subject has role ... Q50430468 (urological agents) urological agents
P2275 World Health Organisation international non-proprietary name Monolingualtext darifenacin ???
External Ids
P267ATC codeG04BD10
P231CAS Registry Number133099-04-4
P683ChEBI ID391960
P592ChEMBL IDCHEMBL1346
P661ChemSpider ID392054
P715DrugBank IDDB00496
P11198DrugCentral ID784
P8494DSSTOX compound identifierDTXCID3028265
P3117DSSTox substance IDDTXSID2048290
P232EC number603-704-1
P2566ECHA Substance Infocard ID100.118.382
P646Freebase ID/m/0ddwfs
P595Guide to Pharmacology Ligand ID319
P595Guide to Pharmacology Ligand ID321
P2057Human Metabolome Database IDHMDB0014639
P234InChIInChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1
P235InChIKeyHXGBXQDTNZMWGS-RUZDIDTESA-N
P665KEGG IDD03654
P10245MedlinePlus drug identifiera605039
P486MeSH descriptor IDC101207
P6366Microsoft Academic ID (discontinued)2779965259
P2115NDF-RT IDN0000023085
P11199Probes And Drugs IDPD009993
P662PubChem CID444031
P1579Reaxys registry number8449641
P3345RxNorm CUI136198
P2877SureChEMBL ID56574
P2892UMLS CUIC0529351
P11089UniChem compound ID357180
P652UNIIAPG9819VLM
P11143WikiProjectMed IDDarifenacin
P3350World Health Organisation international non-proprietary name numeric ID7153

Why not click here or view trends?

log id: 2724339